Latest Hematology & Oncology News
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
posted July 3rd
by modernClinician Editorial Team
by modernClinician Editorial Team
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
posted July 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
Nudging Both Clinicians, Patients May Increase Serious Illness Conversations
posted July 2nd
by modernClinician Editorial Team
by modernClinician Editorial Team
ISTH Issues Clinical Practice Guideline for the Treatment of Hemophilia
posted July 1st
by modernClinician Editorial Team
by modernClinician Editorial Team
Efanesoctocog Alfa Not Cost-Effective for Prophylaxis in Hemophilia A 
Fidanacogene Elaparvovec Superior to Prophylaxis for Hemophilia B 
Efanesoctocog Alfa Prophylaxis Beneficial for Children With Hemophilia A 
Once-Weekly Efanesoctocog Alfa Beneficial in Severe Hemophilia A Related Articles
.jpg)
Most Specialty Oral Anticancer Meds for Blood Cancers Are Initially Rejected by Insurers 
Personalized Support Boosts Families" Genetic Testing for Hereditary Cancers 
Urine Cell-Free RNA Shows Promise as Biomarker for Bladder Cancer 
Pre-Prostate Biopsy MRI Use Increased From 2017 to 2026 Hematology & Oncology Conference Highlights
Hematology & Oncology Monthly Briefings
Hematology & Oncology Conference News
Stay Connected
